Loading…
Armata Pharmaceuticals, Inc. is projected to decline to $3.84 by 2027, a -10% move from its current price of $4.26. ARMP is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean strong sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/11/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 12 | $4.02 | $4.26 | $4.51 | -0.02% |
| Jul 13 | $3.93 | $4.26 | $4.62 | -0.04% |
| Jul 14 | $3.86 | $4.26 | $4.70 | -0.05% |
| Jul 15 | $3.80 | $4.26 | $4.77 | -0.07% |
| Jul 16 | $3.75 | $4.26 | $4.83 | -0.09% |
| Jul 17 | $3.70 | $4.26 | $4.89 | -0.11% |
| Jul 18 | $3.66 | $4.25 | $4.95 | -0.13% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $3.66 | $4.25 | $4.95 | -0.13% |
| Week 2 | $3.43 | $4.25 | $5.26 | -0.25% |
| Week 3 | $3.27 | $4.24 | $5.51 | -0.38% |
| Week 4 | $3.14 | $4.24 | $5.73 | -0.50% |
| Week 5 | $3.02 | $4.23 | $5.93 | -0.63% |
| Week 6 | $2.92 | $4.23 | $6.11 | -0.75% |
| Week 7 | $2.84 | $4.22 | $6.29 | -0.88% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Armata Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company that focuses on the development of targeted bacteriophage therapeutics for antibiotic-resistant infections worldwide. It develops its products using its proprietary bacteriophage-based technology.
The company's product candidates include AP-SA02 for the treatment of Staphylococcus aureus bacteremia; AP-PA03 for Pseudomonas aeruginosa. The company is based in Los Angeles, California. Armata Pharmaceuticals, Inc.
is a subsidiary of Innoviva, Inc.
Armata Pharmaceuticals, Inc. (ARMP) is a clinical-stage biotechnology company focused on the development of targeted bacteriophage therapeutics for antibiotic-resistant infections. Its shares trade at $4.26 per share, and the stock has a market cap of $156.39M. The stock is currently ranked 3966.
A major floor 61.2% below — a decisive break under it would weaken the trend.
Price is testing support right now (0.0% away) — a key level to hold.
The nearest ceiling, 91.8% above — a clean break opens room to run.
A major ceiling 247.4% above — clearing it would confirm fresh momentum.
Key ARMP support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of ARMP market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $4.99 | Sell | $4.96 | Sell |
| MA 10 | $5.71 | Sell | $5.50 | Sell |
| MA 20 | $6.38 | Sell | $6.19 | Sell |
| MA 50 | $7.59 | Sell | $7.40 | Sell |
| MA 100 | $9.10 | Sell | $7.89 | Sell |
| MA 200 | $7.44 | Sell | $7.20 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 24.82 | Buy |
| Stoch RSI (14) | 0.00 | Buy |
| CCI (20) | -177.52 | Sell |
| Williams %R (14) | -100.00 | Info |
| MACD (12,26,9) | -0.17 | Sell |
| ROC (12) | -39.23 | Sell |
| Bollinger %B (20,2) | -0.06 | Buy |
| Stochastic %K (14) | 0.00 | Buy |
| TRIX (15) | -1.25 | Sell |
| Awesome (5,34) | -2.01 | Sell |
| Ultimate (7,14,28) | 11.27 | Buy |
| Momentum (10) | -2.24 | Sell |
| Aroon Osc (25) | -84.00 | Sell |
| Hull MA (9) | 4.49 | Sell |
| ADX (14) | 28.26 | Sell |
| ATR (14) | 0.35 | Info |
RSI14: 20. Sentiment: NEUTRAL. Moving averages show SMA50: $7.59 and SMA200: $7.44. Support is at $4.26 and resistance at $8.17. The 30-day range is $2.93 to $6.20.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $4.26 | $4.26 | $6.10 | 0% | Neutral | |
| $2.79 | $3.84 | $5.73 | -10% | Neutral | |
| $2.68 | $3.93 | $6.24 | -8% | Neutral | |
| $2.19 | $3.37 | $5.62 | -21% | Bearish | |
| $2.18 | $3.52 | $6.12 | -17% | Bearish | |
| $3.29 | $5.56 | $9.98 | +30% | Bullish | |
| $2.99 | $5.28 | $9.78 | +24% | Bullish | |
| $2.56 | $4.70 | $8.95 | +10% | Neutral | |
| $2.66 | $5.08 | $9.91 | +19% | Neutral | |
| $2.19 | $4.34 | $8.68 | +2% | Neutral | |
| $2.92 | $6.49 | $14.25 | +52% | Bullish | |
| $6.28 | $13.95 | $32.09 | +227% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $4.26 | $4.26 | $5.39 | +0.00% |
| August 2026 | $3.65 | $4.42 | $5.58 | +3.75% |
| September 2026 | $3.41 | $4.19 | $5.40 | -5.18% |
| October 2026 | $3.42 | $4.25 | $5.58 | +1.52% |
| November 2026 | $3.61 | $4.53 | $6.03 | +6.58% |
| December 2026 | $3.57 | $4.53 | $6.10 | -0.20% |
Click any year to see its month-by-month ARMP forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
The ARMP price prediction for 2026 points to an average of $4.26 (low $4.26, high $6.10) — a potential gain of 0% on today's $4.26. A consolidation phase looks the most probable path here.
In 2027, ARMP is projected to trade between $2.79 and $5.73, averaging $3.84 — a potential decline of -10% from today's $4.26. That is -10% versus the projected 2026 average. Price action looks broadly range-bound.
Armata Pharmaceuticals, Inc.'s 2028 outlook centres on $3.93, within a $2.68 to $6.24 range. That is up +2% on the projected 2027 average. That marks a -8% change versus current levels. A consolidation phase looks the most probable path here.
By 2029, ARMP could reach as high as $5.62, with a base case around $3.37 and support toward $2.19 — roughly -21% from $4.26. A cyclical pullback looks likely — prices rarely move in a straight line.
Expect ARMP to range from $2.18 to $6.12 through 2030. The $3.52 average target implies a -17% move from current prices. That is up +5% on the projected 2029 average. Expect choppier, lower action through this leg of the cycle.
The ARMP price prediction for 2031 points to an average of $5.56 (low $3.29, high $9.98) — a potential gain of +30% on today's $4.26. Momentum favours further upside here.
In 2032, ARMP is projected to trade between $2.99 and $9.78, averaging $5.28 — a potential gain of +24% from today's $4.26. That is -5% versus the projected 2031 average. Buyers look set to stay in control over this stretch.
Armata Pharmaceuticals, Inc.'s 2033 outlook centres on $4.70, within a $2.56 to $8.95 range. That is -11% versus the projected 2032 average. That marks a +10% change versus current levels. Price action looks broadly range-bound.
By 2034, ARMP could reach as high as $9.91, with a base case around $5.08 and support toward $2.66 — roughly +19% from $4.26. A consolidation phase looks the most probable path here.
Expect ARMP to range from $2.19 to $8.68 through 2035. The $4.34 average target implies a +2% move from current prices. That is -14% versus the projected 2034 average. Price action looks broadly range-bound.
The ARMP price prediction for 2040 points to an average of $6.49 (low $2.92, high $14.25) — a potential gain of +52% on today's $4.26. Buyers look set to stay in control over this stretch.
In 2050, ARMP is projected to trade between $6.28 and $32.09, averaging $13.95 — a potential gain of +227% from today's $4.26. That is up +115% on the projected 2040 average. Momentum favours further upside here.
Investing $1,000 in ARMP today (≈ 234.741784 ARMP) could be worth
$3,274.94
+$2,274.94 (+227%) by 2050 · US Dollar
Based on the average projected ARMP price of $13.95 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in ARMPwould be worth at today's price.
$1,000 invested in ARMP on Jul 10, 2025 (≈ 440.528638 ARMP) would be worth
$1,876.65
+$876.65 (+87.7%) today · 1.88× · US Dollar
Based on a ARMP entry price of $2.27 vs. today's $4.26.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $5.89 | $723.26 | -27.7% |
| 1 month ago | $7.56 | $563.49 | -43.7% |
| 3 months ago | $11.12 | $383.09 | -61.7% |
| 6 months ago | $6.68 | $637.72 | -36.2% |
| 1 year ago | $2.27 | $1,876.65 | +87.7% |
| All time (5.0y) ago | $3.97 | $1,073.05 | +7.3% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our ARMP forecast.
Our base-case forecast reaches $8.50 around 2050.
Implied market cap at $8.50: $312.04M
The year-by-year forecast shows a mixed near-term path with 2026 having min $4.26, avg $4.26, max $6.10 and ROI 0 with a NEUTRAL outlook, followed by declines in 2027–2028 and a BEARISH view in 2029–2030 (2030 avg $3.52, min $2.18, max $6.12, ROI -17.3). From 2031 onward the sentiment shifts to BULLISH, with 2031 avg $5.56 and max $9.98 (ROI 30.4), 2032 avg $5.28 and max $9.78 (ROI 23.9). Long-run upside appears in 2040 (avg $6.49, max $14.25, ROI 52.4) and 2050 (avg $13.95, max $32.09, ROI 227.5).
These figures are estimates and not guarantees, and actual results may differ.
Tap a question to reveal the answer.
2030 min $2.18, avg $3.52, max $6.12; ROI -17.3%; sentiment BEARISH.
Near term shows NEUTRAL to BEARISH signals (2026–2028 neutral, 2029–2030 bearish). From 2031 onward the forecast turns BULLISH with higher potential by 2040 and 2050 (2040 avg $6.49, 2050 avg $13.95). These are estimates and carry uncertainty.
2031 max $9.98 is just under $10, while 2032 max $9.78 remains under $10. By 2040 the max is $14.25 and by 2050 the max is $32.09, indicating higher upside later in the forecast window.
RSI14: 20. Sentiment: NEUTRAL. SMA50: $7.59. SMA200: $7.44. Support: $4.26. Resistance: $8.17. The 30-day range is $2.93 to $6.20.
$156.39M.
Armata Pharmaceuticals, Inc. Community Discussion
0Share your Armata Pharmaceuticals, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.